ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products.

MLA

Talarico, R., et al. “ERN ReCONNET Points to Consider for Treating Patients Living with Autoimmune Rheumatic Diseases with Antiviral Therapies and Anti-SARS-CoV-2 Antibody Products.” Clinical and Experimental Rheumatology, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1375457066&authtype=sso&custid=ns315887.

APA

Talarico, R., Ramirez, G. A., Barreira, S. C., Cardamone, C., Triggianese, P., Aguilera, S., Andersen, J., Avcin, T., Benistan, K., Bertsias, G., Bortoluzzi, A., Bouillot, C., Bulina, I., Burmester, G. R., Callens, S., Carreira, P. E., Cervera, R., Cutolo, M., Damian, L., … Mosca, M. (2023). ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products. Clinical and Experimental Rheumatology.

Chicago

Talarico, R., G.A. Ramirez, S.C. Barreira, C. Cardamone, P. Triggianese, S. Aguilera, J. Andersen, et al. 2023. “ERN ReCONNET Points to Consider for Treating Patients Living with Autoimmune Rheumatic Diseases with Antiviral Therapies and Anti-SARS-CoV-2 Antibody Products.” Clinical and Experimental Rheumatology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1375457066&authtype=sso&custid=ns315887.